Clinical Trials Directory

A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus

A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.


  • drug : Placebo
  • drug : VPD-737

Phase: Phase 2


Ages Eligible For Study:

18 Years - 65 Years

Inclusion Criteria

- Clinical diagnosis of chronic pruritus and unresponsive to current therapies

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Irene Bailey
Not Recruiting

Footer Links: